Citigroup Upgrades Hims & Hers Health (HIMS)

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Stocks HIMS Citigroup Upgrades Hims & Hers Health (HIMS) March 10, 2026 — 08:03 pm EDT Written by George Maybach for Fintel-> Fintel reports that on March 10, 2026, Citigroup upgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Sell to Neutral.

Analyst Price Forecast Suggests 27.68% Upside As of February 25, 2026, the average one-year price target for Hims & Hers Health is $30.00/share. The forecasts range from a low of $13.13 to a high of $63.00. The average price target represents an increase of 27.68% from its latest reported closing price of $23.50 / share. See our leaderboard of companies with the largest price target upside. The projected annual revenue for Hims & Hers Health is 1,205MM, a decrease of 48.67%. The projected annual non-GAAP EPS is -0.20. What is the Fund Sentiment? There are 605 funds or institutions reporting positions in Hims & Hers Health. This is an decrease of 329 owner(s) or 35.22% in the last quarter. Average portfolio weight of all funds dedicated to HIMS is 0.18%, an increase of 39.00%. Total shares owned by institutions decreased in the last three months by 21.68% to 186,607K shares. The put/call ratio of HIMS is 0.59, indicating a bullish outlook. What are Other Shareholders Doing? Jpmorgan Chase holds 18,838K shares representing 8.58% ownership of the company. In its prior filing, the firm reported owning 17,786K shares , representing an increase of 5.59%. The firm decreased its portfolio allocation in HIMS by 36.46% over the last quarter.

Capital World Investors holds 14,323K shares representing 6.52% ownership of the company. In its prior filing, the firm reported owning 18,783K shares , representing a decrease of 31.14%. The firm decreased its portfolio allocation in HIMS by 56.54% over the last quarter.

Goldman Sachs Group holds 10,347K shares representing 4.71% ownership of the company. In its prior filing, the firm reported owning 9,224K shares , representing an increase of 10.86%. The firm decreased its portfolio allocation in HIMS by 35.28% over the last quarter.

Geode Capital Management holds 5,510K shares representing 2.51% ownership of the company. In its prior filing, the firm reported owning 4,901K shares , representing an increase of 11.05%. The firm decreased its portfolio allocation in HIMS by 66.03% over the last quarter. Renaissance Technologies holds 4,818K shares representing 2.19% ownership of the company. In its prior filing, the firm reported owning 9,097K shares , representing a decrease of 88.81%. The firm decreased its portfolio allocation in HIMS by 64.37% over the last quarter. Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.Click to Learn MoreThis story originally appeared on Fintel. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags Stocks Fintel Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford. Check out our Unique Analysis of Insider Sentiment for Hims & Hers Health, Inc.-> Find out what the Options Markets think of Hims & Hers Health, Inc.-> See our take on Hims & Hers Health, Inc. Upcoming Earnings-> More articles by this source-> Stocks mentioned HIMS More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.